SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Discovery " 1,193 found 🔀 AI-powered Shuffle
Ag-Tech Stories: PowerPollen’s ‘grit’ in developing ‘earth-shattering’ technology
Editor’s note: This is the fourth in a series of stories about ag-tech companies and startups. After a year of research, Jason Cope and his team at PowerPollen learned that storing pollen was indeed possible. The discovery came after confronting skepticism from people who had seen it tried before, but with no success. “It’s funny,…
Witkoff and Kushner meet Putin in Moscow for Ukraine talks
(CNN) — Talks between President Donald Trump’s son-in-law Jared Kushner, US envoy Steve Witkoff and Russian President Vladimir Putin are underway in Moscow, after negotiations in Abu Dhabi aimed at ending the Ukraine war concluded without a breakthrough.The US envoys were greeted at Vnukovo Airport on Thursday by Russian presidential special envoy Kirill Dmitriev, the CEO of Russia’s sovereign wealth fund.The trip comes after two days of talks in the UAE capital between Russian, Ukrainian and American negotiators – the first of their kind since February – which Kyiv said made progress on some issues, but did not result in a clear resolution.Speaking after Wednesday’s talks, which lasted less than two hours, Kushner said the purpose of the Moscow meeting was to finalize plans for more humanitarian relief and the release of prisoners, as well as to push to “get Europeans added to the format so we can make this a multilateral format.”While Ukraine has long argued that Europe should be at the main negotiating table, Moscow has so far resisted such efforts.Russian Foreign Minister Sergey Lavrov criticized the presence of European officials in the UAE city earlier this week, saying their involvement was not a “promising approach.”Meanwhile, when asked if there had been any contact between the Russians and any EU representatives in Abu Dhabi, Kremlin spokesperson Dmitry Peskov said Wednesday, “No such contacts were planned, and none took place.”Kushner – who acts as one of the country’s top diplomats despite holding no official role within the Trump administration – and Witkoff are also expected to travel to Dublin to meet with Ukrainian President Volodymyr Zelensky and discuss ideas from the Abu Dhabi talks.Kyiv faces drone attackDespite the flurry of diplomacy, the latest push for peace has not afforded Ukraine respite from the daily barrage of Russian attacks.Moscow launched a ballistic missile and drone attack on Ukraine overnight into Thursday, according to the Ukrainian Air Force. In Kyiv, at least one person was killed, and several others injured amid a Russian drone attack Thursday morning, local authorities said.Zelensky also said Thursday that Starshield – a military-grade version of Elon Musk’s Starlink service that is critical to Ukraine’s military operations – has faced “significant disruptions” in recent days, hampering Kyiv’s ability to shoot down Russian drones.“These are not random errors but systematic speed restrictions. For us, this primarily means a significant complication in intercepting Russian jet-powered drones,” Zelensky posted on X. “We are trying to establish all the circumstances with the American side.”In October too, Ukraine said speed limits were imposed on Starshield satellite terminals, as the relationship between Kyiv and Washington deteriorated. Trump denied approving that decision, while Musk said the Trump administration was behind the restrictions.This story has been updated with additional developments.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Common forever chemicals linked to nearly double the rate of aggressive breast cancer
An NIH study found that women with high levels of two common “forever chemicals” had up to 93% higher rates of an aggressive form of breast cancer. The discovery raises concerns about the potential health effects of persistent chemicals found in everyday products.
Can scientists reverse your age?
Reversing aging may sound like science fiction, but scientists have already found a way to do it—at least, theoretically. Based on a 2012 Nobel-prize winning discovery, researchers are testing whether they can revert diseased cells in the eye back to young and healthy ones. They gave people a drug this year. If it works, it’ll open the door to curing and possibly preventing other age-related diseases. And that led producer Berly McCoy to wonder: Could all this research eventually extend our human lifespans? If you like this episode, check out our episodes on zombie cells, why our hair turns gray and why we die.Interested in more science on aging? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.
PSI is trying to make a business out of AI-driven scientific discovery
PSI used an unreleased Anthropic model to answer a fundamental question about quantum computing that scientists have pursued for nearly two decades.
OpenAI rolls out new business profiles, making ChatGPT just a little bit more like Google
OpenAI is looking to make ChatGPT a more robust consumer discovery engine, and a host of new features seek to empower businesses to help it do that.
NYT: Trump wished Biden well in newly disclosed 2021 letter
(CNN) — In his forthcoming book, former President Joe Biden discloses the contents of a 2021 letter written by President Donald Trump as he prepared to leave the White House after his first term, according to an excerpt of the book and a copy of the letter obtained by The New York Times.“Many presidents have come and gone who simply governed as Republicans or Democrats,” Trump wrote in the letter to Biden, according to Times. “Largely, they did not change history, they were just swept along in its relentless tide. This will not happen to you because I know how much you love the American people.”Biden has previously alluded to a “very generous letter” left by his predecessor, and now successor, but until now had declined to talk about the contents.The reported letter, which was dated January 20, 2021, strikes a different tone than Trump’s public statements after losing the election to Biden in 2020. Trump repeatedly claimed the election was stolen and refused to conduct an orderly transfer of power to his successor, challenging the results in court and pressing his allies to move to block the certification of his loss.The matter came to a head when Trump supporters stormed the US Capitol on January 6, 2021, as Congress was voting on whether to certify the results. While Congress ultimately certified Biden’s victory, Trump has continued to deny the 2020 results and pardoned over 1,000 people involved in the riot when he returned to the White House last year.“Not only are you joined by the past, but you carry the hopes and dreams of the entire nation on your shoulders. The gravity of that fact never leaves you, it is the anchor that grounds every decision you make,” Trump wrote in the letter.“Your strength, your deepest reservoir of energy, comes from the knowledge that millions upon millions of people are depending on you. Their ambitions and aspirations are the reason you are here, with so many counting on your success,” he continued.Biden was inaugurated the same day as the letter and Trump did not attend the festivities as is customary for most living presidents. Trump has sharply criticized Biden in the years since the 46th president left office.In his book, titled “Promise Me, America,” Biden writes it was “as if there were two Donald Trumps” and says Trump “deeply destabilized democracy,” according to the Times.“But here he was, offering his best wishes in warm language that sounded like it was coming from an old friend,” Biden wrote in the book, which is set to be released next Tuesday.In a statement to the Times, White House communications director Steven Cheung said, “Joe Biden should have heeded the president’s wise words, but instead he tried to destroy this country and weaponize the justice system against his political enemies.”“Biden is a disgrace, and America is better off with him no longer as president,” Cheung added.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Vermont measles: cases confirmed in Orleans County, state health agency says
The Vermont Department of Health did not provide the number of cases on Monday or identify the community in Orleans County where testing led to the discovery.
Science Takes Center Stage At The Niswonger With Mr. C's The World In Motion
recently welcomed more than 1,000 students from Van Wert City Schools in grades 1–7 to the Niswonger Performing Arts Center for an exciting morning of science, discovery, and entertainment! Students
Skydance Games Hit By Layoffs
A number of staffers at Skydance Games have been laid off following merger with Warner Bros. Discovery.
Baby right whale discovered off Canada gives scientists cause for joy
Scientists who study whales are heartened by an unexpected discovery of a baby right whale off Canada.
The fierce battle for James Bond is playing out in public
(CNN) — It’s been five years since Daniel Craig bid farewell to the role of 007 in “No Time to Die,” which ended with a closing credit promise that “James Bond will return.” And while corporate machinations have slowed the character’s reappearance, the battle to play cinema’s most famous secret agent is playing out more publicly than usual.In recent weeks, there have been numerous leaks to the press about the slew of big-name actors said to be auditioning for Bond in what will be the 26th film in the franchise, stoking debates among fans.Last month, it was reported that “final screen tests” were being held, with “One Night Only” heartthrob Callum Turner, “Slow Horses” actor Jack Lowden and Josh O’Connor of “Challengers” said to be among those who made the cut. Then two surprise names entered the mix over the weekend, with Deadline and Variety reporting “Primetime” star Robert Pattinson and “X-Men” actor Nicholas Hoult had also undergone screen tests for the role. (Pattinson’s casting would be particularly remarkable given he’s also currently leading another major franchise as Batman, while Hoult is appearing as Lex Luther in the new “Superman” movies.)Other wild cards, per Variety? Pop singer Harry Styles or “The White Lotus” star Theo James. At 32, Styles would be the youngest choice, while 41-year-old James is the oldest.Representatives for the actors and Amazon MGM Studios, didn’t respond to requests for comment. None of the actors have revealed what the audition process has involved, although O’Connor told the BBC that being considered was an “incredibly bizarre pinch-me moment.”A ‘methodical’ huntProducer Amy Pascal, who steered “Spider-Man” to several reboots over her career, has said fans can expect a decision by the end of the year. “We are being really, really methodical,” she told Deadline this summer. “Daniel Craig is a hard act to follow. And it’s got to be something really different that is a stirring and exciting and different.”There is immense pressure to get the decision right. For one, the Bond franchise is big business, with Craig’s “No Time to Die” earning more than $900 million. (In 2022, Amazon paid $8.5 billion to acquire Bond’s parent company, MGM.) But the role also occupies huge cultural real estate as one of the most identifiably “British” characters in film.Just six actors have portrayed Bond. Sean Connery first appeared as the suave, shaken-not-stirred secret agent in 1962’s “Dr. No.” Tradition has it that the role should be played a Brit, although George Lazenby, an Australian, played Bond in 1969’s “On Her Majesty’s Secret Service.”Pierce Brosnan, who played 007 in four movies, appeared to back Turner in an interview with Vanity Fair last week, saying the husband of Dua Lipa was a strong actor. “They all have a voice and a physique, and a presence on film,” Brosnan said of the final candidates. “They all have longevity as actors, all of these young men.”“Whoever plays the role, I wish him the very best of life and strength and courage,” he said.The next Bond movie will be directed by Denis Villeneuve, who knows a thing or two about working in a franchise, given he has overseen the “Dune” trilogy. At a Los Angeles gala on Saturday, Villeneuve appeared to be reveling in the media’s focus on the battle for Bond.“I should not comment right now because every word I’m going to say is going to be scrutinized,” Villeneuve told Variety. “I would just say that I’m having a great time.”The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.THE-CNN-WIRE (TM) & © 2026 CABLE NEWS NETWORK, INC., A TIME WARNER COMPANY. ALL RIGHTS RESERVED.
Instituto Galo's weekly round-up
November 3 – A passion for Galo in every discovery! 🖤🤍Labareda’s rhythmic gymnasts took part in Instituto Galo’s Charity Tour, getting an up-close look at Atlético’s history and the ico...
Meet Drops, the new music app bringing back the fun of sharing songs with friends
The new music discovery app lets users scroll through 10-to-30-second snippets of songs, comment, and share with friends.
AN2 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business and Scientific Highlights
MENLO PARK, Calif., November 09, 2026--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the third quarter ended September 30, 2026 and recent business and scientific highlights.
For Science: Studies suggest expert competitive gamers have an edge in real world decision-making speed
Making split-second decisions while under the pressures of PvP game combat isn't necessarily what one would call a breakthrough science discovery, but there is a recently published study that finds expert players of competitive games such as Counter-Strike and League of Legends do have a cognitive edge when making quick decisions in the real world as well. The [...]
Scientists identify a completely new type of rock in a Martian meteorite and find garnet on Mars for the first time, but its planetary origin remains unconfirmed
An international team of scientists has identified a completely new type of rock on Mars and, for the first time, found the mineral garnet in a Martian sample. The discovery came from a fragment of the Martian meteorite NWA 8171, held in the Royal Ontario Museum’s collections, and was led by Tanya Kizovski of Brock University.
Ruben Mesa: Discovery Science Driving Progress in Cancer Research
Ruben Mesa: Discovery Science Driving Progress in Cancer Research / Atrium Health Wake Forest Baptist, cancer, Cancer research, Discovery Science, OncoDaily,
Earth's rocks have a missing layer spanning up to a billion years. Scientists finally know what happened to it
The 'Great Unconformity' has puzzled scientists since its discovery in the 1870s
Scientists Determine Mysterious Pink Rock Found in Sahara Desert Is 4.1 Billion-Year-Old Piece of Mars
The rare discovery could help scientists unlock new clues about the Red Planet’s ancient history
State health officials set to remove remaining materials at illegal Reedley biolab
Four years after the discovery of an illegal biolab in Reedley, city leaders say the final materials remaining inside the building are expected to be removed and destroyed next week.
Scientists discover Europe's ancient forests were nothing like we imagined
Scientists have uncovered evidence that Europe was dominated for more than 20 million years by open woodlands, colorful meadows, and large grazing animals, not the dense forests long considered its natural state. The surprising discovery challenges modern reforestation strategies, suggesting that planting thick forests could actually harm the biodiversity conservationists hope to protect.
Scientists discovered an unknown baby right whale off Canada. They say it's a cause for joy
Scientists who study whales are heartened by an unexpected discovery of a baby right whale off Canada. Researchers in Canada captured images of an unidentified baby North Atlantic right whale, one of the rarest sea mammals in the world, off Anticosti Island in Quebec in September. Scientists with...
Scientists discovered an unknown baby right whale off Canada. They say it's a cause for joy
Scientists who study whales are heartened by an unexpected discovery of a baby right whale off Canada
Scientists discovered an unknown baby right whale off Canada. They say it's a cause for joy
Scientists who study whales are heartened by an unexpected discovery of a baby right whale off Canada
New wave of health and STEM candidates could reshape US science policy
A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical trials led the news this week.
New wave of health and STEM candidates could reshape US science policy
A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical trials led the news this week.
FSU chemists develop light-powered method to resurrect 'dead-end' compounds for drug discovery
Throughout the drug development process, which can take a decade or more, tens of thousands of chemical compounds are produced that never go on to become
Two-step synthesize superconducting hydride at lower pressures
In a paper published in the Journal of the American Chemical Society researchers experimentally synthesized for the first time Mg2RhH6 that exhibits superconductivity at a significantly reduced pressure of 30 GPa. Mg2RhH6 was synthesized via a two-step process and showed superconductivity with a maximum Tc of 29 K. The findings open a highly promising pathway for the rational design and discovery of high temperature superconductors at accessible pressures for industrial pressure facilities.
County Awards Berks LaunchBox $125K for Small Business Grants
Of the total grant awarded, $12,000 will be set aside for Penn State Berks student entrepreneurs participating in the college’s Flemming Creativity, Entrepreneurship, and Economic Development Center Customer Discovery Lab, which will be distributed to awardees in $1,000 increments.
New Mexico Museum of Natural History & Science Celebrates 40 years of discovery
By Sara Atencio-Gonzales, The Paper. – From prehistoric fossils to the mysteries of outer space, the New Mexico Museum of Natural History & Science has spent four decades bringing the state’s scientific history to life. Now, as the museum celebrates its 40th anniversary, staff members are reflecting on its evolution while preparing several special events…
New Mexico Museum of Natural History & Science Celebrates 40 years of discovery
By Sara Atencio-Gonzales, The Paper. – From prehistoric fossils to the mysteries of outer space, the New Mexico Museum of Natural History & Science has spent four decades bringing the state’s scientific history to life. Now, as the museum celebrates its 40th anniversary, staff members are reflecting on its evolution while preparing several special events […]
Arizona Science Center unveils new fall exhibits focused on caves and creativity
Arizona Science Center is expanding its lineup of interactive experiences this fall with two new attractions designed to engage guests through hands-on exploration, creativity and scientific discovery.
UK backs startup Potential Sciences' AI-powered drug hunt
UK startup Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.
UConn Gathering Connects the Science of Reading with Classrooms Worldwide
A student exchange with Hebrew University builds on Haskins’ history of discovery and its work with educators close to home and around the world
How do octopuses remember? Scientists uncover a surprising secret
How do octopuses remember what they learn? A new study reveals a surprising “molecular switch” in the octopus brain that helps preserve memories by keeping connections between nerve cells strengthened over time, without the need to produce new proteins. The discovery sheds new light on one of nature’s greatest mysteries: how creatures with vastly different brains evolved remarkably sophisticated learning and memory abilities.
400,000-year-old teeth reveal a stunning twist in human evolution
A groundbreaking discovery is rewriting the story of human evolution, revealing that an ancient human species once thought to be an evolutionary dead end may have left genetic traces in people alive today. By extracting proteins from 400,000-year-old Homo erectus teeth discovered in China, scientists uncovered evidence suggesting that these early humans interbred with Denisovans, another mysterious ancient human group. That genetic connection may have eventually reached modern populations in the Philippines, Papua New Guinea, and other parts of Southeast Asia.
OpenAI Finds 948 Local Privilege Escalation Bugs In The Linux Kernel
OpenAI published a blog post outlining their work on autonomous vulnerability discovery
When papers become currency: a Chinese debate about trust in science
Last Saturday, 31 October, I went to the University of Hong Kong’s Beijing Centre for its Talent Forum. It was the fourth stop in the series this year, following events in Shanghai’s Zhangjiang, Shenzhen’s Qianhai, and on HKU’s main campus. The programme covered a remarkable distance in one afternoon. HKU’s Xiao-Jing Wang discussed computational neuroscience, intelligence, and the prefrontal cortex—before even delivering his inaugural public lecture to students back in Hong Kong. His colleague Bing Zhang took us from the Big Bang to artificial intelligence. Tsinghua’s Xue Lan asked how AI might reshape the institutional infrastructure underpinning higher education. There were lively panels featuring industry leaders from JD.com, Xiaomi, Haier—and Kaiser Y Kuo on the closing panel discussing innovation and international connections. I cannot pretend to have followed every detail of the brain models or the astrophysics. The talk that stayed with me was closer to something we have covered before: Zhou Zhonghe 周忠和 on papers, evaluation, and scientific trust. Zhou is a palaeontologist, an Academician of the Chinese Academy of Sciences, and an international member of the US National Academy of Sciences. He is also editor-in-chief of The Intellectual (知识分子), China’s leading science commentary platform. His subject was uncomfortable enough for a room full of successful academics: what happens when the system for recognising good science starts rewarding something else? Part of my interest came from our sister newsletter, The East is Read, which covered the controversy around “Geng Tongxue” in May. A PhD dropout from Beihang University, Geng has publicly challenged papers by prominent researchers through detailed online allegations of manipulated images and fabricated data. At Tongji University, an investigation into a challenged Nature paper found academic misconduct, and the dean of its life sciences school was removed. The affair brought doubts about academic integrity well beyond laboratories and university committees. How could someone outside the established hierarchy spot problems in papers that had passed through prestigious journals and institutions? And what, exactly, had all that prestige guaranteed? Zhou approached these questions through two essays published in July by The Intellectual: one by Wang Xiaodong, director of the National Institute of Biological Sciences, Beijing, and a response by Wang Liming, of Shanghai’s Shangsi Institute of Natural Sciences. Both began with the controversy over Geng. Their arguments deserve a wider audience, so I want to put parts of them alongside what Zhou said on Saturday. Wang Xiaodong’s starting point is evolution. A research system selects for the behaviour it rewards. Grants, jobs, journals, talent programmes, and prizes collectively determine which scientists prosper and which practices get passed down from advisors to students. “Whatever the system rewards is what it will evolve to produce,” he writes, citing the ancient Chinese saying: The King of Chu loved slender waists, and many in the palace starved to death. That is a more demanding diagnosis than saying there are dishonest people in science. Punishing a fraudster does not change the selective environment that made a particular kind of research profitable. His account also gives scientific success an awkward role in the story. As Zhou put it on Saturday, science became a victim of its own success. Once research became central to industry, national power, and economic growth, universities and laboratories expanded, and public money followed. That created an administrative need for rapid decisions: who should get the next grant, the next laboratory, the next appointment? The difficulty is that the true value of a discovery may take years or decades of testing and building to become clear. Resource allocation cannot wait that long. Publication counts, journal prestige, impact factors, and citations therefore become convenient ways to make an instant judgement. “The real problem is not that these indicators have no value,” Wang Xiaodong writes, “but that they are trying to answer a question that only time can answer.” Telling administrators simply to stop counting papers will never be enough. They still have budgets to distribute and appointments to make. Something has to replace the shortcut. Zhou described the consequences inside publishing. Papers acquire ever more requirements: a complete story, polished presentation, extensive datasets, and accessibility to readers beyond the immediate field. Individually, those demands sound reasonable. Together, he warned, they produce formulaic “eight-legged” papers 八股文 and rigid reviewing, while genuinely original or non-consensus work struggles to get past journal editors—some of whom wield immense gatekeeping power despite having limited laboratory experience themselves. Meanwhile, the demands for sprawling, “complete” narratives have fuelled a wider replication crisis. Wang Xiaodong uses a mahjong metaphor to describe the result: put the complex papers published by the exact same lab over several years side by side, and they often look like “Thirteen Orphans” (十三不靠)—every tile completely unrelated to the next, and none of them reproducible by outsiders. Zhou also spoke frankly as an editor who has trouble finding reviewers. Everyone wants someone else to review their work; qualified senior researchers have little time to return the favour. The labour is anonymous, unpaid, and brings almost no institutional recognition, so it increasingly gets passed down to postdocs and graduate students. And while anonymity protects reviewers from rank and personal favours, hyper-specialisation means an author’s most qualified reviewer is often a direct competitor, shielded from accountability. The protection and the problem coexist. Wang Liming takes the argument a step further. The decisive change, in his essay, is the instant conversion of academic honour into material resources. Once a paper can be cashed in for funding, a job, students, commercial investment, or even a company valuation, scientists are alienated from their work: they must keep minting this “research currency” to keep their teams alive. He is careful not to romanticise the past. The old world of gentleman scientists—financially independent figures like Boyle and Darwin who needed nothing from external funders—was also a closed club that excluded people without inherited wealth, women, and much of humanity outside the West. Professional science allowed ordinary people, himself included, to become researchers. Nobody should want to undo that. The problem, in his account, is an exchange system that becomes too uniform and too difficult to correct. His most pointed Chinese example is the “hat” (帽子): the prestigious talent designation that brings continuing access to money, laboratory space, students, and institutional influence. “If papers are the circulating currency of the research system, then a ‘hat’ is a bond that pays interest over the long term,” he writes. A paper at least requires another round of peer review. A title in the Chinese context can lock in a judgement made years ago and turn it into permanent status rent, regardless of whether its holder is still doing good science. Here, official institutions hire, organise, and evaluate scientists. Unlike honours awarded by autonomous academic communities in the West, a Chinese “hat” blends non-scientist administrative power with state authority. Once granted, it turns a past judgement into permanent status rent that is nearly impossible to revoke—because taking a hat off would imply that official authority erred in putting it on. Both Wangs see China as experiencing, at compressed speed, pressures present across global science. Research expansion, rising investment, publication growth, and elaborate evaluation metrics arrived in China within two or three decades rather than two or three centuries. Zhou agreed with that international framing—noting that recent US White House science policy documents and the new president of the US National Academy of Sciences, a fellow palaeontologist who recently visited Zhou’s institute in Beijing, have raised strikingly similar warnings about consensus-bound peer review, short-term project grants, and the replication crisis. Still, Zhou emphasised that China’s traditional hierarchy, personal networks (guanxi), and the ethos that “a good scholar becomes an official” (学而优则仕) amplify those pressures at home. So what would change things? Here Zhou’s tone differed from the call for a revolution in scientific trust in Wang Xiaodong’s essay. As an evolutionary biologist, Zhou favoured patchwork repair (修修补补). Living systems survive through accumulated adjustments; dramatic mutations are usually fatal. Science cannot return to a small, slow-moving pastoral era, especially after the successive accelerations of professionalisation after the Second World War, the internet, and now artificial intelligence. But it can alter the local environment in which researchers work. He pointed to domestic experiments designed to support unconventional research and diversify funding, including Tencent’s New Cornerstone Investigator Program, the Xplorer Prize, and the Future Science Prize. He also mentioned participating in reviews for “major non-consensus projects” under the National Natural Science Foundation of China. One guiding principle he recalled was wonderfully direct: “Failure is allowed; corruption is not” (允许失败，不允许腐败). That distinction would mean quite a lot if taken seriously. An honest attempt that fails should not have to disguise itself as a success to survive an assessment. Wang Liming’s essay adds a sharp caveat to the optimism about new domestic funders. Multiple organisations do not automatically produce multiple ways of judging science. If the same pool of senior domestic scientists makes the decisions through the same two-round review procedures, it is still “fake diversity.” He argues for three distinct kinds of money: broad baseline funding governed by fair procedures; patient funding for questions that take ten years; and non-consensus funding based on individual taste, deliberately empowering a few genuine experts to make biased, contrarian bets on eccentric ideas that would inevitably be averaged out by a committee. Replacing one monopoly with another achieves little; a healthy ecosystem needs variance. Zhou’s proposals for publishing were similarly concrete: strip papers of their resource-allocation burden and return them to recording discoveries and establishing priority; separate dissemination from evaluation, as eLife and Peer Community In do; adopt more modular “micro-publications” and real-name endorsements; recognize the labour of editors and reviewers; and give replication work proper credit rather than treating it as an unpublishable dead end. AI makes every part of this debate more urgent—and Zhou wove it throughout his talk. In his own preparation, he used AI to survey the declining influence of academic monographs, noting how tools are already changing how scholars gather information. More fundamentally, he placed AI as the latest great acceleration in scientific history: just as the internet sped up the pace of research and tightened external resource pressures, AI is compressing the cycle again. In the essays Zhou cited, AI cuts both ways. Wang Xiaodong expects large language models to erase much of the English-writing disadvantage long faced by Chinese scientists, further swelling the flood of papers coming out of Chinese labs. Wang Liming sees AI accelerating both ends of the trust crisis: it lowers the cost of paper mills and fabricated images just as quickly as it lowers the cost of automated image forensics, data auditing, and code reproduction. “Whoever builds the verification layer wins,” Wang Liming writes. His proposed alternative to the static, packaged “story paper” is a continuously versioned “unit of discovery” containing a falsifiable claim, raw data, analysis code, experimental parameters, and an ongoing log of independent checks—where negative results and failed replications are recorded rather than buried. Zhou ended his keynote by bringing AI back to the question of scientific honour and credit. Citing a recent Intellectual discussion on “What AI Means for Mathematics” featuring Fields Medalist Deng Yu 邓煜—at a moment when AI is already batch-solving mathematical conjectures, as HKU Vice-President Lin Chen noted in his opening remarks—Zhou agreed that human researchers must remain the principal agents: AI is a tool that frees scientists from tedious calculation to think about deeper, messier real-world problems. Yet that partnership creates a thorny new evaluation problem. When a breakthrough is made with AI, what is the human contribution and what is the machine’s? And since AI models distil centuries of accumulated human scholarship, is it right that the credit and value flow so heavily to the private AI companies building the tools? The old struggle over how to assign scientific honour is acquiring a whole new layer. What I took away was a serious discussion of how science can remain trustworthy as its scale, incentives, and tools change. These were scientists with real standing inside China’s system questioning how that standing is produced, and proposing changes that would affect their own institutions and peers. That made the afternoon at HKU’s Beijing Centre worthwhile. At the close, Wang Feng, Director of Communications and Public Affairs at HKU, said the value of the forum series—which heads to Hangzhou in December and cities like Chengdu early next year—would lie in the real cooperation it helped bring about. The university has plenty to celebrate: this week it topped the QS Asia rankings for a second consecutive year, alongside its 11th-place position in the QS World University Rankings 2027. For me, bringing this debate to an audience beyond the people who review papers and allocate grants was a useful contribution. Share [ The East is Read PhD dropout’s exposé forces an academic fraud reckoning in China A former doctoral student turned blogger has shaken China’s academic establishment by publicly accusing prominent university scholars of fabricating data and manipulating papers, triggering investigations at several leading institutions and drawing rare attention from state media… Read more 5 months ago · 43 likes · 8 comments · Yuxuan JIA ](https://www.eastisread.com/p/phd-dropouts-expose-forces-an-academic?utm_source=substack&utm_campaign=post_embed&utm_medium=web&embedding_publication_id=47580)
Scientists solve 30-year-old mystery and discover a hidden defense against inflammation
Scientists have solved a decades-old mystery and uncovered a hidden immune system defense that protects healthy cells from the very inflammation meant to fight infections. The surprising discovery could lead to new approaches for treating cancer, inflammatory bowel disease, and other conditions involving excessive inflammation.
Always Asking Why: The Drive Behind UCF Nursing Leader's Passion for Healthcare
As the dean of the College of Nursing and Orlando Health Endowed Chair in Nursing, Sharon Tucker has transformed curiosity into discovery, leadership and new possibilities for the future of healthcare.
U.K. Culture Secretary Scrutinizing Comcast-Owned Sky's Acquisition of ITV Media & Entertainment
U.K. Culture Secretary Lisa Nandy Nov. 4 disclosed that she will look into Comcast-owned Sky’s $2.15 billion acquisition of ITV’s Media & Entertainment, which includes its free-to-air channels and the ITVX streaming platform. In a statement, Nandy, who most-recently conducted an 11th hour investigation of Paramount’s $111 billion merger with Warner Bros. Discovery, says she … Continue reading "U.K. Culture Secretary Scrutinizing Comcast-Owned Sky’s Acquisition of ITV Media & Entertainment"
AI in Life Sciences Market to Worth USD 69.34 Billion by 2031, at a CAGR of 26.3%
Delray Beach, FL , Nov. 04, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global AI in life sciences market to grow from USD 21.58 billion in 2026 to USD 69.34 billion by 2031, at a CAGR of 26.3% during the forecast period. Market growth is fueled by accelerating adoption of AI in drug discovery, clinical research, diagnostics, and precision medicine, along with increasing investments in AI-powered life sciences solutions and the growing availability of real-world and genomic data. Ge
A surprising discovery could help aging muscles repair themselves
Scientists have discovered a compound that transforms a natural muscle-repair protein into a more powerful version dubbed "Super HGF," more than doubling its ability to bind to a key receptor while protecting it from age-related chemical damage. The breakthrough, supported by early mouse experiments, could eventually help combat muscle loss and preserve strength as people age.
SLAC scientists find conclusive proof of a mysterious third type of magnetism
For nearly 90 years, scientists believed magnetism fell into just two categories, but researchers have now confirmed a remarkable third type called altermagnetism. Using specialized X-rays, they uncovered a unique magnetic signature that proves these materials behave differently from conventional magnets. Altermagnets combine stability with the ability to efficiently carry information, potentially overcoming major limitations in today's electronics. The discovery could lead to faster computers, more efficient data centers, and breakthroughs in quantum technology.
The brain’s hidden fear mechanism may explain anxiety and PTSD
A surprising new discovery suggests that fear may cause the brain to blur the line between danger and safety rather than distinguish them more clearly. By observing brain activity in mice using augmented reality, scientists found that memories of threatening and harmless environments began to overlap, potentially allowing faster responses to danger. This "better safe than sorry" survival mechanism could help explain why people with anxiety or PTSD sometimes experience intense fear in completely safe situations.
Scientists discover a surprising clue to autism's origins hidden in the placenta
Scientists have uncovered an unexpected connection between inflammation during pregnancy, placental damage, and autism-like traits in male mice, while females appeared naturally protected. The discovery could help explain why autism is diagnosed more frequently in boys and reveal new opportunities for early intervention.
Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that it will release its financial results for the quarter ended September 30, 2026 and provide a business update on November 10, 2026.
Live Sports Coming to Algorithm-Driven Feeds on Discovery Platforms
Over the last 90 days, TikTok has quietly started including full sports broadcasts within users’ feeds. It’s believed the strong performance will prompt the company to add more live sports and that other discovery platforms could quickly follow suit, potentially creating several new distributional channels for rights owners.
When you invest in the Seymour Center, you create scientists like Ellie
My name is Ellie Giles, and I’m a sophomore in the Marine Studies program at Oregon State University. The Seymour Center has been so many things to me: a community, a place of discovery, and even a second home. I still remember my first field trip there in second grade, being instantly drawn to the […]
Nintendo tried adding fast travel to The Legend of Zelda: Ocarina of Time remake, before devs realised "we were missing out on the moments of discovery"
Nintendo tried to add Breath of the Wild-style warp points to the Ocarina of Time remake, but quickly realised the feature didn't mesh with the N64 classic.
UCT researchers name 400 000-year-old fossilised termite nests after Little Karoo town
University of Cape Town (UCT) researchers recently named a series of approximately 400 000-year-old fossilised underground nests of an extinct termite species after Calitzdorp, the Little Karoo town near which they were found. In October 2026, the research team returned to the town to donate a poster documenting their discovery to the Calitzdorp Museum, helping to connect local communities with the region’s remarkable fossil heritage.
Scientists Find Two New Armored Water Bears on Atlantic Seamount
A deepwater survey of an Atlantic seamount has turned up something extraordinary lurking in the seabed sediment, and the discovery raises surprising questions about which ocean environments harbor the...
Scientists discover that some “unhealthy” diets can boost cancer immunotherapy in mice
In a surprising discovery, scientists found that certain diets associated with obesity can make cancer immunotherapy more effective in mice, challenging traditional assumptions about diet and cancer treatment. The findings suggest that the secret may lie in how food interacts with gut bacteria to strengthen the immune system's response to cancer.
China found giant ‘chimneys’ in deep water that could impact submarine warfare
Discovery of how surface wind energy plunges to the ocean floor could improve underwater acoustic detection and marine communication: study.
Anthropic's IPO filing shows how it's boosting biotech research
Anthropic's S-1 filing says Claude can accelerate drug discovery and biology research, making life sciences central to the AI company's IPO pitch.
A surprising vitamin A discovery is changing what scientists know about vision
Scientists at Johns Hopkins University have uncovered a surprising process that helps humans develop sharp vision before birth, challenging decades of assumptions about how the eye forms. Using miniature human retinas grown in the lab, researchers discovered that a vitamin A derivative and thyroid hormones work together to shape the foveola, the tiny region at the center of the retina responsible for our sharpest vision.
In defense of ‘useless knowledge’
At Frontiers of Science lecture, Nobel laureate Martin Chalfie celebrates what drives scientific discovery.
2026-2027 Audree V. Fowler Fellows in Protein Science
Graduate students Lenka Milojević (Zhou group), Akshaya Narayanasamy (Lindert group), Sarah Singleton (Conway group), and Janet Zhong (Feigon group) have been selected as 2026–27 Fowler Fellows and shared their research at a special event on Oct. 13, 2026. 2026-27 Fowler Fellows – Sarah Singleton, Lenka Milojević, Janet Zhong, and Akshaya Narayanasamy. Akshaya Narayanasamy and Prof. Steffen Lindert. Sarah Singleton and Prof. Stuart Conway. Janet Zhong and Prof. Juli Feigon. About the 2026-27 Audree Fowler Fellows in Protein Science Lenka Milojević is a fifth-year Biophysics Ph.D. candidate in the lab of Professor Z. Hong Zhou at UCLA. As an undergraduate at Maastricht University, she studied the structural basis of Mycobacterium tuberculosis virulence and amyloid-β fibril nucleation in the lab of Professor Peter Peters. She completed her bachelor’s thesis research at UCLA in the lab of Professor David Eisenberg, focusing on amyloid disaggregation, before beginning her doctoral studies. In the Zhou lab, Lenka uses cryo-electron tomography to visualize and characterize membrane-associated protein assemblies across a range of viral and cellular systems. Akshaya Narayanasamy is a fifth-year Ph.D. student in the Department of Chemistry and Biochemistry at UCLA, mentored by Professor Steffen Lindert. She earned her B.S.-M.S. in Chemistry from the Indian Institute of Science Education and Research, Thiruvananthapuram, where she worked in Professor Mahesh Hariharan’s lab investigating how single-atom substitutions influence crystal packing and charge transport behavior. She received her M.S. in Physical Chemistry from The Ohio State University before moving with the Lindert lab to UCLA. At UCLA, Akshaya develops integrative modeling methods that combine deep learning and Rosetta with experimental data, such as ion mobility mass spectrometry and cryo-EM, to improve protein structure prediction. Her current work focuses on developing an experimentally guided diffusion model and designing de novo protein binders with potential antibacterial activity. Ultimately, she aims to bridge AI-based structure prediction and experimental data to make computational protein models more reliable for drug discovery and therapeutic design. Sarah Singleton is a 4th year BMSB student, working in Professor Stuart Conway’s lab. She earned her B.S. in Biochemistry at Simmon University (Fenway, MA). Her research is centered on drugging the previously undruggable class of proteins—transcription factors. Zinc finger (ZF)-containing transcription factor proteins typically contain multiple ZF motifs, but little is known about the principles that govern the recognition of multi-ZF arrays by immunomodulatory imide drugs (IMiDs). In a multi-ZF array that contains several potentially targetable ZFs, which will be accessible and why? How does the surrounding protein architecture inform IMiD recognition? Sarah’s research aims to utilize her findings on the fundamental principles of ZF recognition to design IMiD therapeutics for transcription factors involved in health and disease. Janet Zhong is a fourth-year BMSB student, working in Professor Juli Feigon’s laboratory. She received her BSc and MRes from Imperial College London. At UCLA, Janet combines cryo-electron microscopy (cryo-EM) and biochemical approaches to investigate how proteins and RNAs assemble into ribonucleoprotein structures. Her research focuses on telomerase, the enzyme that maintains chromosome ends, with interests in its structure, assembly, and mechanisms. She has also worked on capturing the cryo-EM structure of a small bacterial non-coding RNA called raiA motif RNA. About Dr. Audree Fowler A strong supporter of the basic sciences and medicine at UCLA, alumna Dr. Audree Fowler (B.S. ’56 chemistry, Ph.D. ’63 biochemistry) established the Audree V. Fowler Fellows in Protein Science in 2008. Fowler was Director UCLA Protein Microsequencing Facility from 1984-1999 and is a Researcher Emeritus of the UCLA Department of Biological Chemistry. She is one of the first four women to receive a Ph.D. from the UCLA Department of Chemistry & Biochemistry. In 2018, the women were awarded the department’s 2018 Alumni Legacy Awards in recognition of their achievements in life, and generous support and service to UCLA. “The sciences gave me a great life. Now I want to help others have access to the same opportunities I enjoyed,” Fowler explained when she established the Fowler Fellowships endowment. Applications for the fellowships are solicited from graduate students in the Molecular Biology Interdepartmental (MBI) Ph.D. Program, Biological Chemistry, and Chemistry & Biochemistry Departments. In addition to presenting their research at a special seminar, the recipients each receive a $5,000 award. Previous Fowler Fellows from the UCLA Department of Chemistry & Biochemistry 2025-26 – Nikki Cheung (Clubb Group), Jonathan Jih (Zhou Group), Eileen Olivares (Loo Group), and Lily Taylor (Rodriguez Group) 2024-25 – Andrew Goring (Clubb lab), Eric Pang (S. Clarke and Rodriguez labs), and Miranda Villanueva (Backus lab) 2023-24 – Alexandra Turmon (Backus lab), Cindy Wang (S. Clarke and C. Clarke labs) 2022-23 – Cody Gillman (Gonen lab), Declan Evans (Houk lab), Troy Lowe (S. Clarke lab), Ashley Julio (Backus lab), and Alex Stevens (Hong Zhou lab) 2021-22 – Weixian Deng (Wohlschlegel/Plath labs), Yi Xiao “Sean” Jiang (Eisenberg lab), Maria Flores (Rodriguez lab), Carter Lantz (Loo lab), and Logan Richards (Rodriguez lab). 2020-21 – Janine Fu (Loo lab), Calina Glynn (Rodriguez lab), and Jiahui Lu (Eisenberg lab) 2019-20 – David Boyer (Eisenberg lab), Orlando Martinez (Clubb lab) and John Muroski (Loo lab) 2018-19 – Scott McConnell (Clubb lab), Kevin Murray (Eisenberg lab), Rebeccah Warmack (S. Clarke lab) 2017-18 – Michael Hughes (Eisenberg lab), Yuxi Liu (Yeates lab), Kanishk Jain (S. Clarke lab) 2016-17 – Brendan Amer (Clubb Lab) and Jeff Vinokur (Bowie Lab) 2015-16 – Henry Chan (Feigon lab), Smriti Sangwan (Eisenberg lab), Nicholas Woodall (Bowie lab) 2014-15 – Dan McNamara (Yeates lab) 2013-14 – Alex Jacobitz (Clubb lab), Alexander Patananan (S. Clarke lab), Carly Ferguson (Loo lab) 2012-13 – Letian Xie (C. Clarke lab), Anni Zhao (Eisenberg lab) 2011-12 – Timothy Anderson (Clubb lab), Soohong Kim (Weiss lab) 2010-11 – Zeynep Durer (Reiser lab), Cecilia Zurita-Lopez (S. Clarke lab) 2009-10 – Luki Goldschmidt (Eisenberg lab), Kristofer Webb (S. Clarke lab), Sheng Yin (Loo lab) 2008-09 – Nathan Joh (Bowie lab), Neil King (Yeates lab) Photos courtesy of Helen Houldsworth, the Molecular Biology Institute.
SebastianStrong Foundation Discovery Science Award 2027 - Oncology News, Insights, Stories by OncoDaily
The SebastianStrong Foundation Discovery Science Award 2027 supports research developing more targeted, less toxic treatments for childhood cancers. The
Sci-Port Discovery Center brings spooky science to Shreveport
SHREVEPORT, La.— Sci-Port Discovery Center is celebrating the Halloween season with hands-on science activities, themed fitness events and trick-or-treating for local families along the Red River.
Science Begins With Wonder and Sometimes With a Salamander.
The Bar Harbor Story is generously sponsored by the Don & Beth Straus Center at Birch Bay Village. BAR HARBOR—The children had come to see the axolotls, those odd little salamanders with pink frills around their heads and the remarkable ability to grow back what they lose. But also there were stickers. There were crafts. There was the kind of excitement that makes a roomful of kindergarteners forget, for a little while, that sitting still is ever a requirement. And then there were the animals themselves, alive in their clear cases at the MDI Biological Laboratory, where 12 children from Pemetic Elementary School got to meet the creatures they had been learning about in class. “Do you love them?” their teacher, Carol Null, asked. The answer came back in a chorus. “I do!” “I do!” “I do too,” Null said, smiling. “I love them even more now.” That was the thing about a day at the lab. Science was no longer a picture in a book, or a word on a classroom wall. It had a face, a tail, and a set of extraordinary powers. And for a child, sometimes that is where wonder begins. Sometimes learning about science is about stickers. Sometimes it’s about bright pink feathers and getting super excited about that glow in the dark. Sometimes learning about science is joy—pure and simple joy. That’s how it was October 28 at the MDI Bio Lab as Miss Hannah (known in the lab as Dr. Hannah Lust, director of STEM, undergraduate and graduate Training), other scientists, graduate students, and MDI Bio Lab staff, hosted 12 students from Carol Null’s Pemetic Elementary School’s kindergarten class. The 2.5-hour program created by Dr. Lust focused on axolotls, a species of mole salamanders, a superhero in the animal world: a superhero with some scientific-study worthy superpowers. One of those superpowers come from the axolotls’ ability to regenerate body parts, including entire limbs. But also, they’re cute. This fall, before coming to the internationally renowned lab nestled in Salsbury Cove, Null has been integrating axolotls into her class. They’ve been part of the kids’ vocabulary and their storytelling. They’ve been part of science. They’ve been part of the children’s learning about facts vs opinions. The Pemetic Elementary kindergarten students learn about invasive species and the impact on the ecology and one student related it to their dad, who lobsters, and his worries about green craps, an invasive species in Maine. “Are they bigger or smaller than you thought they’d be?” the children are asked after the scientists show them multiple see-through cases of axolotls, lined up on a table that they’re told not to jiggle. “Bigger!” “I think they’re bigger.” “Smaller!” The bio lab opening its doors to the collaborations and to students and families is a norm, but this is the first program of this kind. It’s meant to encourage kindergarten students about axolotls. But when the students come to the bio lab something else happens too—something beyond Null’s child-focused teaching—the students see science—and the regenerating creatures in real life. They do crafts. They speak with them. They meet people who know all about them: scientists and educators who talk to the kids like they’re equals. That’s a superhero power, too. Null speaks about meeting the kids where they’re at in her classroom, letting their interest and hearts lead her in their learning. That requires recognition of interests, of individuality, of empathy. Some would argue that’s a super power, too, but it’s also in those 12 students as they listen to the storybook, encounter those live axolotls, and hear about how axolotls might help advance society’s understanding of human health. As Eddie Seckeler (comparative animal models, CORE facility manager), carefully puts the axolotls on a cart and rolls them away, some of the children stop what they’re doing to watch. “Bye axolotls.” “Bye!” “Bye!” The axolotls are not just images in a book, Hello, I’m an axolotl by Hayley and John Rocco; they are real and cool. MDI Biological Laboratory scientists Dr. Prayag Murawala and Dr. James Godwin who both feature in the Roccos’ book. The kindergarteners get to meet them in real life, off the page, in the world, doing science. They learn from them, laugh with them. “The visit is about more than meeting an unusual animal. By introducing children to scientists working in their own community, the experience helps make science tangible and accessible. Students can see that science is not just something they read about in books or learn about at school. It is something real people do every day by asking questions, making observations and working to understand how the world works,” explains MDI Biological Laboratory Director of Communications Rebecca Woods. While the students make axolotl-related crafts around tables, graduate students and staff help out. Ryan holds up his construction paper setting and axolotl to show Omar Maged, a graduate student. “Do you like it?” Ryan asks, eyes wide, turning from his axolotl to look up at Omar. Omar studies the construction paper for a moment, smiles and says definitively, each word important. “It is beautiful.” Null says that she’s so thankful for all the “amazing” community partners that her school and her students get to interact with as they learn and grow and live, but emphasized how the MDI Bio Lab goes out of its way to create something meaningful, something that allows her young students to build their own agency, to know that they can be impactful in their community, to show them how how things they learn about in text is connected to themselves and their community. Woods explains, “Axolotls have an extraordinary ability to regenerate, or regrow, certain body parts, including limbs. Scientists study these animals to understand how regeneration works and what their biology might teach us about tissue repair and healing in humans.” The children enter the space for “a memorable introduction to a big scientific question,” Woods said. “How can some animals regrow body parts? The encounter encourages children to look closely, wonder about what they see and begin to understand how scientists use observations and experiments to investigate questions.” “For the students, the visit is an opportunity to explore a fascinating animal and meet scientists in their own community,” Woods explains. “For MDI Biological Laboratory, it is a chance to share the excitement of research, nurture curiosity, and help young learners discover that science begins with asking questions.“ At the beginning of the school year, Pemetic kindergarteners didn’t know what the axolotl was—at least not exactly—now they know all about the axolotl’s life cycle. “It’s different than a butterfly,” one student told Mrs. Null. It is. The change and knowledge might seem small**,** but it offers a glimpse of what happens when a subject moves beyond the pages of a book and into a child’s world. The children have been learning about butterflies at the Charlotte Rhoades Park and Butterfly Garden. At both the garden and the MDI Bio Lab, the children see the animals, meet the scientists who study them and at the lab encounter a question that researchers are still working to answer: how can some creatures regenerate body parts, and what might that teach us about healing in humans? They leave with gift bags, paper-plate salamanders, new things to wonder about and a connection between the science they learn in school and the work happening in their own community. The axolotls may be remarkable for their ability to grow back what they have lost. For these young students, the day offers something different: a chance to discover how much there is to ask, observe, and imagine. When Null’s students had time to use chalk and draw whatever they want, in the beginning of the year, they drew rainbows. Now? They’re using that chalk and choosing to draw axolotls instead. About MDI Bio Laboratory For more than 125 years, MDI Bio Lab has been a center for training and research in comparative biology. In the last two decades its biomedical research has focused on aging, regeneration, and environmental toxins. The Laboratory houses 11 research groups staffed by an international team of world-class scientists and graduate students. It also leads a statewide network of colleges, universities and research institutions that collaborate to provide training, research experiences and financial support to help young Mainers play a bigger role in today’s biomedical revolution. Located on Maine’s rugged coast, the Laboratory’s 100+ acre campus houses research facilities, cottages and dorms that house visiting scientists and students. It is also home to MDI Bioscience, a subsidiary working to design innovative techniques to speed the drug discovery process. The Bar Harbor Story is generously sponsored by Rick Osann Art. LINKS TO LEARN MORE NIH INBRE MDI BIOLOGICAL LABORATORY Pemetic Elementary School Hello, I’m an Axolotl Photos: Carrie Jones/Bar Harbor Story HELP SUPPORT THE BAR HARBOR STORY When we started The Bar Harbor Story, we didn’t know if anyone would read it. But you showed up. You shared. You sent tips. Now—over 400,000 views every month later—it’s clear: people here care about their community and each other. We’ve kept everything free because news should never be out of reach, but every one of our stories takes time to write, and your support keeps The Bar Harbor Story going. If you value our work, please consider a paid subscription, a founding membership, or a sponsorship. It truly helps us cover one more meeting, tell one more story, shine one more light. Even $5 a month makes a difference. Click here to become a one-time supporter now. Thank you so much for being here. Founding member information can be found here. Have questions about sponsorships? Just send Shaun an email at sfarrar86@gmail.com, he’d love to hear from you. Subscribe Share Bar Harbor Story Share Leave a comment
The Longest Eclipse Left This Century Now Has Its Own Science Tour in Spain
New Scientist Discovery Tours has five new trips for 2027, from fossil digs in the Australian outback to jaguar tracking in Brazil.
GW Is a Founding Partner in Hugging Face’s Project ProtoStar, a National Effort to Make Publicly Funded Science AI-Ready
The George Washington University is a founding partner in Project ProtoStar, a partnership with Hugging Face and other research institutions and universities to accelerate scientific discovery. The initiative aims to make publicly funded datasets, models and code easier for people and AI systems to find, understand and reuse. GW’s participation is led by its Open Source Program Office (OSPO).
FSU Discovery Days: Arts-Humanities-Health Symposium fosters interdisciplinary collaboration
Florida State University artists, scientists and therapists united at the Arts-Humanities-Health Symposium during Discovery Days to explore how the arts
A single brain signal may explain schizophrenia's most puzzling symptoms
Scientists have identified a weakened brain signal that may connect several seemingly unrelated symptoms of schizophrenia, including sensory processing difficulties, disorganized speech, and greater symptom severity. The surprising discovery could help explain the disorder's underlying mechanisms and potentially lead to earlier detection and new treatments.
A golden age of science is coming
It’s almost hard to remember, but just a few years ago, a lot of very smart people thought that science was in terminal decline. Respected researchers were writing papers with titles like “Are Ideas Getting Harder to Find?”, “Papers and patents are becoming less disruptive over time”, and “Slowed canonical progress in large fields of science”. In 1996, science writer John Horgan even published a book called The End Of Science: Facing The Limits Of Knowledge In The Twilight Of The Scientific Age. The fundamental idea was that the Universe only has so many insights to discover, and that we’ve picked the low-hanging fruit. It was the idea that Joseph-Louis Lagrange expressed when he said that “we cannot find more than once a system of the world to establish.” As the big ideas and the simple ideas get mined out, we’re forced to throw ever more brains at the mysteries of nature just to keep scientific progress going at a fraction of its old pace: It looked like science was hitting a wall. Then along came AI. It’s far too early to tell how much AI will eventually speed up the growth of total factor productivity. But already we can see signs of a speedup in science. Anthropic Founder Jack Clark assembled some of the hopeful data points in a recent lecture: [ Dror Poleg@drorpoleg "If you pick different parts of science, you see the same pattern show up: Progress is accelerating, and it has started to accelerate in the last two years." Jack Clark @jackclarkSF I’m speaking at the IMF in an hour about the singularity and why I believe it has begun and the choices we'll need to make. Watch live here: https://t.co/Hj9HzcXx5h 6:08 PM · Oct 18, 2026 · 21.2K Views 2 Replies · 10 Reposts · 123 Likes ](https://x.com/drorpoleg/status/2111882070376980529) Anthropic is accelerating its investment into drug discovery, and is already announcing some impressive preliminary results: [ BioTender@Junioryu136689 BREAKING: Anthropic unveils early results from six Claude-powered drug development collaborations. • 70% shorter CAR-T signaling domain • ~35,000 antibody designs • >10× tighter antibody binding • 89% less batch-record review time Still largely preclinical. Anthropic @AnthropicAI Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of 9:43 PM · Oct 27, 2026 · 11.2K Views 3 Replies · 24 Reposts · 205 Likes ](https://x.com/Junioryu136689/status/2115197821150495150) Claude also appears to be enabling rapid progress toward a treatment for food allergies. OpenAI, meanwhile, announced a possible breakthrough treatment for neurodegenerative disease. Meanwhile, Google Cloud Chief Scientist Pushmeet Kohli has a list of recent scientific advances that have been enabled by its new Gemini model, including breakthroughs in nuclear fusion reactor design, rare disease research, and quantum computing: [ Pushmeet Kohli@pushmeet Gemini 4 Argon is a step change in model performance. In recent weeks, it has had a transformative impact on the Science projects in our team at @GoogleDeepMind and our external collaborators, and helped make a number of remarkable advances across scientific disciplines. 🧵👇 4:47 PM · Oct 13, 2026 · 36.5K Views 8 Replies · 41 Reposts · 497 Likes ](https://x.com/pushmeet/status/2110049807385702623) But as cool as these stories sound, they’re just very minor, preliminary efforts. There are a number of reasons to think that AI is going to propel us into a golden age of scientific discovery. That age might not last forever — AI might still run into diminishing returns eventually. But the next few decades are probably going to be an absolutely amazing time for human science. The number of “effective researchers” is no longer limited The most important input into science is scientists themselves. Until this year, that meant human brains — talented, highly trained human brains. The number of trained human brains could be increased by sending more people to grad school, but only to a point — the smartest people tend to be sent into the hardest research fields first, and if you 10x the number of researchers, the average quality will go down. This constraint was already starting to bite, as Ekerdt and Wu argued in 2024: We argue that a substantial portion of the downward historical trend in U.S. research productivity is a composition effect resulting from self-selection in researcher ability and the dramatic expansion of the research sector…[W]e find that this composition effect has lowered average researcher ability by between 37% and 53%[.] And of course, low fertility was making the problem worse, because fewer children meant fewer people who were able to become future scientists. AI just blows up this constraint completely. If an AI agent can function as an autonomous researcher, there’s no constraint on the number of researchers in the world — you can just build more of them, by building more computer chips and data centers that enable the running of more AI agents. Whether or not massive hordes of agents can collaborate to solve individual problems much faster, increasing the number of agents allows them to tackle many different research questions in parallel. What’s more, these AI “researchers” can be trained incredibly quickly compared to human beings. A human scientist takes decades to train, and more years to reach the frontier of their research field by diligent reading and conversation. This is the “burden of knowledge”, and it’s commonly believed to be one reason ideas have been getting harder to find — by the time human scientists can get up to speed, they’re often so old that their ideas are no longer novel. AI just annihilates this constraint — it can assimilate the entire literature and reach the frontier of research extremely quickly, and it can also tell human scientists where the frontier lies without forcing them to discover that for themselves. It can also pivot to new research directions more easily than humans can. And there’s also a self-reinforcing economic cycle here. Because scientific advances enable higher GDP, they enable more resources to be invested into the creation of yet more electronic “scientists”. Now that doesn’t mean the amount of scientific research goes to infinity — there may still be some essential bottleneck task that human researchers are still needed to perform. There are some indications that AI’s progress on open-ended conceptual research tasks is slower than in other dimensions, and it may be that humans are still needed to provide some of this long-term conceptual thinking. I’d bet against this being true for much longer, but it might be true for a long time. Even in this most “pessimistic” case, though, the amount of effective capital that scientists can use to leverage their work just went up by a lot. AI eliminates the theory bottleneck Science proceeds by an iterative process of theory and experiment. The theory part of that cycle is typically short, but non-trivial — it took a couple of years after the blackbody radiation spectrum was observed for Max Planck to come up with the quantum hypothesis to explain it, and decades longer before quantum theory as we now know it was created. It took about a year for Watson and Crick to figure out the shape of DNA after the requisite data was gathered. AI will basically eliminate the theory bottleneck entirely — or at least shorten the turnaround time between experiment and theory by an order of magnitude. AI is an absolute beast at math. Recently, an OpenAI model solved some of the most important open problems in computer science, math, and theoretical physics, and no one even batted an eyebrow because that sort of triumph is becoming increasingly commonplace. One of those solutions was a proof that the Standard Model of Particle Physics could be mathematically well-defined — a problem that human theorists had so far been unable to tackle. Not all research relies equally on theory, but understanding novel experimental results almost always involves some important component of either mathematical or spatial reasoning. That part of the task has now been made much, much faster. And on top of that, science is now open to a greater number of humans who aren’t naturally good at theorizing. AI can read the whole literature Much of the work of human scientists involves reading and understanding endless amounts of papers and going to endless conferences and seminars. The purpose of that work is to understand the existing scientific literature. Understanding the literature allows scientists to do the following things: Come up with new ideas for hypotheses to test Avoid doing research that someone else has already done Synthesize approaches from different areas or fields AI can reduce this effort to almost zero. Consider this excerpt from OpenAI’s blog post about their new research into neurodegenerative disease: The team divided the analysis among thousands of AI agents powered by GPT‑Rosalind, an approach we call distributed biological reasoning. The agents examined a whole-brain CRISPR atlas…a dataset showing how gene disruptions affect different types of cells across the mouse brain. Each agent investigated a gene disruption, analyzed cellular responses, searched scientific literature, and proposed explanations for the results. Their reports were combined into a reasoning atlas linking genes, cellular effects, relevant publications, and possible biological mechanisms. The research team estimated that comparable human analysis and literature review, conducted one perturbation at a time, would take months to a year. The agents reproduced findings from human analyses while uncovering additional leads. Their assessments of novelty and scientific value also aligned with judgments from blinded human experts. These findings help prioritize further experiments needed to test the proposed biological mechanisms. Some of these insights point to new leads for understanding brain disease. [emphasis mine] This is one case in which parallel work by a large number of agents really does make a huge difference: [ Haider.@haider1 this is actually insane openai deployed thousands of GPT-Rosalind agents to analyze millions of mouse brain cells in 32 minutes, work that could take human researchers months to a year also the agents uncovered new leads for brain diseases like Alzheimer's and Parkinson's OpenAI @OpenAI GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration? DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in 2:41 PM · Oct 21, 2026 · 51.5K Views 26 Replies · 95 Reposts · 1.26K Likes ](https://x.com/haider1/status/2112917197903540516) Not only does instantaneous literature review vastly speed up the research process, but it allows AI to make novel conceptual leaps from combining approaches from wildly different fields of research. AI regularly does this in math research, combining results, approaches, and theorems from far-flung places that no human mathematician would have thought to combine. It can do it in science, too. Much of scientific innovation, historically, has been “recombinant” innovation — scientists applying insights from one field to another. With AI, essentially all research is now cross-disciplinary — AI can read not just the literature on a particular subject, but the literature on a million other subjects that might have produced useful techniques or insights for the problem at hand. Superscience So far, all of the factors I’ve listed are ways that AI can speed up science as it’s already done. I’ve basically described how AI can send gigantic hordes of superhumanly fast, superhumanly well-read, superhumanly mathematically gifted researchers to re-accelerate scientific discovery. But it’s also possible that AI will enable types of discovery — and ways of understanding the natural world — that no network of humans, no matter how large or how brilliant it was or how long it had to work, would ever be able to discover. In a post back in July, I wrote about how that might work: What if there are lots of…aspects of the Universe that [are] too complex to understand in terms of simple laws, but not so complex that they just dissolve into unknowable chaos? It’s possible that we can reliably control these complex phenomena with AI, even if we never reduce them to the kind of principles that we can teach a grad student in a textbook… Another way of saying this is that there may be laws of the universe that humans can’t understand but AI can. I call these “cloud laws” — causal regularities that can be exploited by technology, but which are too diffuse and complex for an individual human being to either intuit or communicate… Perhaps social sciences like economics, sociology, and political science obey similarly complex regularities, and AI can help us find them. Perhaps there are physical processes — plasma, or topological materials, or aerial turbulence, etc. — that obey cloud laws instead of chaos?… [H]uman collaboration is bottlenecked — it’s limited by our ability to intuit patterns at an individual level, and to communicate these patterns from one individual to another. AI, being a computer, just doesn’t have this sort of limitation; it can work with vast, diffuse patterns without having to break them into pieces or simplify them in order to compress them into the tiny pipelines of person-to-person explanation… If much of the Universe turns out to be ruled by cloud laws, we could be on the precipice of a scientific renaissance. In order to discover cloud laws, AI will need huge amounts of data about the natural world. AI figured out human speech by assimilating essentially all of the text humans have ever written. If it’s going to figure out hidden patterns in biology, neuroscience, materials science, etc., it’s going to need similarly massive amounts of data from physical instruments. That data will be far, far more than humans — individually or collectively — would be able to parse, label, characterize, or model. But AI was built to do this. If scientists simply build huge arrays of sensors to measure complex phenomena like the brain, the cell, the economy, etc., they may be able to feed this flood of data to AI directly and bypass human cognitive intermediation entirely. AI would then learn about the world directly, and it might learn things that humans never could. This “superscience”, if you want to call it that, would actually go beyond the kind of science humans have done heretofore. Many of the technologies it yielded would be beyond human comprehension — indistinguishable from magic. But to the AIs, they would make perfect scientific sense. In any case, it seems clear that the scientific slowdown that threatened human progress will now be delayed — at least for a while. Unless humans have somehow found most of the actual exploitable regularities in our Universe, we’re about to enter a new golden age of science. Subscribe Share
Global Health & WASH
The US National Institutes of Health reopened its center and program-project machinery in force. NIGMS is funding Collaborative Program Grants for interdisciplinary teams, NIAID opened both its Immune Tolerance Network and a next-generation R&D call, the NCI runs its Carcinogen Hazard Assessment Monographs program, the National Library of Medicine is funding institutional training in biomedical AI and data science, and NIH reopened its Centers for AIDS Research. The tell: these pay for standing centers and multi-year consortia at institutions with an existing funded research base, not one-off projects, so the fit is an established US research institution, not a single investigator. Disease-specific foundations are again funding the researcher, not just the research. The Parkinson’s Foundation opened its Paul Oreffice Innovations in Care Award and the National Ataxia Foundation its Research Seed Money Grant. The tell, the same one we flagged last cycle, is a named early-career or seed award that builds a pipeline of scientists committed to one condition, so what wins is a researcher willing to specialize. The post-USAID global-health money is routing through a State Department program statement and multilateral innovation funds. The US Department of State’s Bureau of Global Health Security and Diplomacy opened its Advancing Global Health Annual Program Statement, Grand Challenges Canada opened Nexa Lighthouse for climate and health innovation in Asia and the Pacific at USD $250,000 to $2,000,000, and CEPI opened a rolling call on vaccine-manufacturing analytics. The tell: the largest health money this cycle sits in a standing program statement and in staged innovation vehicles, not in a single bilateral grant. Total Estimated Funding Pool: ~$35.4M across discrete grants. (Separately, large national-formula envelopes not counted in this total: U.S. Department of State, Bureau of Global Health Security and Diplomacy (GHSD).) This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. New opportunities: Paul Oreffice Innovations in Care Award, Parkinson’s Foundation. *New!* *Closing soon!* The Parkinson’s Foundation created the Paul Oreffice Innovations in Care Award to fund clinicians rethinking how people with Parkinson’s disease receive care. The Foundation is using pilot funding to move promising ideas into testable projects, backing work across four lanes: strengthening community clinician capability, redesigning care models, building patient-centered technologies, and defining the minimum clinical datasets that make better standards possible. It wants hypothesis-driven, clinically grounded projects that can generate evidence strong enough to attract further funding. By opening the door to clinicians at every career stage and strongly preferring projects that involve people with Parkinson’s in their design, the Foundation signals that it values practical, patient-shaped innovation over prestige. The strongest fits are US-licensed clinicians with a focus on Parkinson’s and an institutional home for applied care research. Geographies: united states. Who can apply: Clinicians of all career stages, from fellows to established faculty, who are licensed to care for patients in the United States and have a significant focus on Parkinson’s disease. Physicians must have completed a neurology residency (or justify how their training pathway benefits people with PD); allied health professionals must hold an advanced degree, typically a PhD. Fellows, those in mentored positions, and those within two years of starting an independent position require a mentor and a mentor support letter. The sponsoring institution’s grants office is the authorized recipient and funds are disbursed to the institution. Funding amount: Maximum of $200,000 over two years; up to three awards. Targeted Sectors / SDGs: Health; Innovation; Science & Technology. Deadline: November 1, 2026. Learn more and apply here. Design and Deliver the Next EIT Health Bootcamps, EIT Health. *New!* *Closing soon!* EIT Health is opening its call for consortia to design and deliver the next generation of its health start-up bootcamps, funding the curriculum, masterclasses, mentoring, and investor engagement that turn early health ventures into fundable companies. The organization is using these learning paths to strengthen Europe’s health innovation pipeline across digital health evidence, deep tech and AI commercialization, cross-border investment, and patient access. What EIT Health wants to back is not a single course but durable delivery capacity built by partners who span industry, education, and research. Requiring multi-country consortia and a revenue-sharing stake in the programs signals that EIT Health expects these bootcamps to outlast the grant. The strongest fits are established training providers, universities, and industry partners with proven reach into health entrepreneurs. Geographies: Europe. Who can apply: Consortia only (individuals cannot apply), comprising a minimum of two and a maximum of five independent legal entities. Partners must cover at least two sides of the Knowledge Triangle (industry, education, research), including at least one industry organisation, and at least two entities must be legally established in different Horizon Europe countries. Funding amount: Foundational Learning Path: up to EUR €112,000; Thematic Learning Paths: up to EUR €124,500 per path (up to four thematic projects); up to EUR €610,000 total EIT Health funding available under the call. Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. Technology Transfer Offices & Entrepreneurship Support Call (Beyond the Lab: From Research to Venture), EIT Health. *New!* *Closing soon!* EIT Health is opening its Technology Transfer Offices and Entrepreneurship Support Call to fund consortia that will deliver the Beyond the Lab: From Research to Venture program for healthcare researchers. EIT Health is using the grant to build local capacity for turning laboratory science into incorporated start-ups, paying experienced technology transfer offices and entrepreneurship support providers to run masterclasses, structured mentoring, and a closing Pitch Day across two cohorts. It wants to back organizations that can walk researchers from discovery to company formation, not just teach theory. Requiring two transfer offices plus one venture-building provider signals that EIT Health values proven commercialization experience alongside academic reach. The strongest fits are European research-commercialization teams with a track record of moving health innovations toward investable ventures. Geographies: Europe. Who can apply: A consortium of two Technology Transfer Offices (representing higher education institutions or research organisations) and one Entrepreneurship Support Provider with demonstrated experience in venture building and start-up support. Applicants may apply for more than one learning path where they can demonstrate the required expertise and capacity for each. Funding amount: Up to EUR €77,000 in 2027 and up to EUR €77,000 in 2028 (up to EUR €154,000 total per consortium over two years). Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. EIT Health RIS Country Representatives Call (2027-2028), EIT Health. *New!* *Closing soon!* EIT Health is seeking organizations to serve as Country Representatives across eleven Regional Innovation Scheme countries in central and eastern Europe for the 2027 to 2028 period. The money funds a national anchor in each country, an organization that maps the local health innovation ecosystem, connects startups and researchers to EIT Health programs, and builds the stakeholder relationships that let health ventures grow. EIT Health is backing local capacity rather than individual projects, which is why it accepts both single organizations and national consortia that span education, research, and industry. The requirement for co-financing signals that it wants representatives already embedded in their national systems. The strongest fits are established ecosystem builders with deep ties to health innovation stakeholders in one eligible country. Geographies: Croatia; Czech Republic; Estonia; Greece; Hungary; Latvia; Malta; Romania; Serbia; Slovenia; Turkey. Who can apply: Registered legal entities established in one of the eligible EIT RIS countries. Single organisations or national consortia may apply. Consortia must include at least two sides of the Knowledge Triangle (education, research and industry), and all consortium partners must be established in the same eligible country. Suitable applicants have demonstrated experience in healthcare innovation ecosystem development, innovation support and entrepreneurship, start-up acceleration, technology transfer, research and higher education, business support, and stakeholder engagement, with strong links to national innovation stakeholders. Funding amount: Up to EUR €182,000 per Country Representative (maximum funding per project); total call budget up to EUR €1,274,500; EIT Health funds up to 60% of total eligible project costs. Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. Architects of Trust: Community-Driven Demand Creation for New TB Vaccines, Treatment Action Group (TAG). *New!* *Closing soon!* Treatment Action Group, with funding from Wellcome, is opening its Architects of Trust call to help communities prepare for the new tuberculosis vaccines now moving through late-stage trials. The money backs civil society and community-based organizations to raise awareness, surface local questions and concerns, and press policymakers toward equitable national rollout. By pairing each grantee with an advocacy mentor and running a strategy workshop alongside the Global TB Vaccine Forum, Treatment Action Group is building a durable advocacy bench rather than funding one-off outreach. The two-stage design, starting with a short expression of interest, signals that fit and community rootedness matter more than polished proposals. The strongest fits are locally trusted groups with real TB, immunization, or health advocacy experience and a committed project lead. Geographies: Brazil; Ethiopia; India; Indonesia; Kenya; Malawi; Mozambique; Nigeria; Peru; Philippines; South Africa; Tanzania; Vietnam; Zambia. Who can apply: National, subnational, or regional civil society organizations (CSOs) or community-based organizations based in one of the 14 eligible countries or in Eastern Europe/Central Asia regional networks, with experience in TB, immunization, or other health advocacy and in community engagement or policy advocacy; well integrated into stakeholder networks with membership or affiliation to other CSO or community networks; naming a dedicated project lead (’architect of trust’) who can attend the April 2027 Zaragoza forum in person; and holding (or committing to adopt) organizational policies on safeguarding (bullying, harassment, abuse, and harm), equity, diversity and inclusion, and legal compliance, research practice and governance. Funding amount: Grants of up to US$45,000 will be awarded to 8 CSO partners across 14 high-TB-burden countries plus regional networks in Eastern Europe and Central Asia; each grant funds 12 months of work. Targeted Sectors / SDGs: Health; Governance; Policy & Advocacy. Deadline: November 4, 2026. Learn more and apply here.
128,000-year-old ice in Tibet could rewrite climate history
Ancient ice discovered high in Tibet may be more than 128,000 years old, preserving an extraordinary record of Earth's climate that scientists previously thought had been lost. The discovery reveals a rare glimpse into the last ice age and could reshape our understanding of how glaciers survive dramatic changes in global climate.
FSU Discovery Days event reveals the beauty of science through crystal photography
Science and art came together at Florida State University's "Glittering Science" event Oct. 21, where photographs of tiny crystals revealed the unexpected
Judge allows discovery in civil suit appeal of $2B state contract awarded to political heavyweights
A Massachusetts judge is allowing discovery in an appeal in a civil suit over a $2 billion state contract for a new Springfield courthouse awarded, in-part, to politically connected bidders.
Dassault Systèmes Completes ArisGlobal Acquisition to Expand Life Sciences AI Platform
VELIZY-VILLACOUBLAY, France, Oct. 28, 2026 — Dassault Systèmes today announced it has completed the acquisition of ArisGlobal and is now uniting its Life Sciences and Healthcare capabilities into a unified AI platform that connects science, medicine and patients. The milestones advance its ambition to improve people’s lives by empowering faster drug discovery, better therapies and […]
Scientists discover a hidden 100-million-year-old volcanic system
Scientists have uncovered a long-lost volcanic system in Iran that dates back roughly 100 million years, revealing a hidden chapter in Earth's tectonic history. The discovery sheds new light on the disappearance of an ancient ocean and the powerful geological forces that reshaped the Middle East.
Let's Talk: Youth — A champion, a colorful legacy and science that glows
Young people across East Tennessee are finding opportunities to shine, whether through athletic competition, scouting or scientific discovery. This week, we’re celebrating a Bearden Middle School champion, a special Girl Scout experience inspired by Dolly Parton and a classroom challenge that could take fifth graders to Dollywood. Bearden Middle School student wins Pan American championship […]
Giving quantum computers a way to pick up where they left off
FIU is researching how to restart quantum workflows after interruptions to preserve computational progress. It lays the groundwork for quantum machine learning for drug discovery and climate modeling.
Skydance offers voluntary buyouts, mandates five-day office week after $110 billion Warner Bros Discovery deal
The media giant is looking to rein in costs and manage an estimated $80 billion debt burden as it integrates Warner Bros Discovery and prepares to outline its strategy to investors.
Skydance offers voluntary buyouts to some employees
Skydance Corp. is offering some employees a one-time voluntary buyout, a move that comes nearly three weeks after Paramount Skydance closed its $111 billion acquisition of Warner Bros. Discovery. The
Skydance offers voluntary buyouts to some employees
Skydance is offering a one-time voluntary buyout offer to certain employees, as Paramount and Warner Bros. Discovery merge operations.
Scientists Discover a Plant Compound That Could Help Stop Rheumatoid Arthritis Inflammation
Scientists have identified a plant compound that reduced joint swelling and inflammation in rats with experimental arthritis. The discovery offers a potential new direction for rheumatoid arthritis tr...
Low-dose aspirin linked to 70% lower dementia risk, but there's a catch
A common, inexpensive medication could hold an unexpected clue to preventing dementia. Researchers found that older adults with a specific genetic profile had a 70% lower relative risk of dementia when taking low-dose aspirin, even though previous studies found no overall protective effect. The discovery suggests that genetics could help explain why some people benefit while others do not.
Netflix’s Leadership Shake Up…Explained
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Well, I had a simple article planned for this week. Called “Whoa, I Missed It!”, I’d take a gander at a few important-but-under-the-radar stories I didn’t cover while I wrote about all things “Skydance. (Formerly known as “the saga of Netflix trying to buy Warner Bros., but not Discovery, then Paramount-Skydance bought all of Warner Bros. Discovery”.) Alas, that article will have to wait. Netflix made news. Ironically, my “Whoa, I Missed It!” article would have mostly been about “content” strategy decisions, which is also what today’s article is about. But instead of the entire industry, this article will only cover Netflix’s decision to upend their film and TV content teams. Just that! So that’s the full topic of the day. I’m going to tackle the issue in the opposite direction of the way “stuff” flows: uphill. We’ll start at film, then move onto TV, and then onto the CEOs themselves, and the strategy questions that still remain. But we start with the numbers driving this. Let’s dive in. Subscribe Most Important Story of the Week - Netflix Upends Their Corporate Hierarchy I’ve got a lot of thoughts, but we’ll start with the most common response to yesterday’s article. Let’s Talk Stock Price More than one person, responding to what I published two days ago, pointed out that, well, actually, the thing driving Netflix’s actions is this: In short, stock price! Even if Netflix isn’t obsessed with their own share price—they probably are, but, for the record, my strategic advice to every CEO is to absolutely ignore stock prices, which will, ironically, probably help the stock price long-term—most everyone thinks they are. By the way, I prefer market capitalization to stock prices, because it’s a more apples-to-apples way to compare companies: But there’s an even better way to look at it, and it kinda casts some doubt on the entire push here: price-to-earnings. I have a long list of articles that I wish I had written, and chief among them is an article titled, “Am I Still a Netflix ‘Bear’?” meaning someone who thinks Netflix’s stock is overvalued. As of last summer, Netflix had solved their biggest problem—which for me (circa 2019) was the lack of free cash flow—but their stock was CRAZY overvalued. That’s this chart here: Why did Netflix’s stock price increase to a price-to-earnings ratio of 50 last summer? What financial metric changed so quickly? Nothing. Given that, historically, mature entertainment companies average 10 to 20, with 16 being the average, that increase made little sense. Netflix’s stock swoon these last eight or so months wasn’t irrational; the stock price rise last year was. So if you want a really hot Netflix take, here it is: Netflix’s stock price has been going down because the financial industry recovered its senses, not because of any strategic mistake. Yes, that would imply that cleaning house may have been a mistake. That’s why the charts yesterday are so important, because they show that Netflix did have a strategic problem (a lack of hits) and that’s what they moved to address. (One could also argue the industry drastically overrated Netflix’s growth prospects, but that’s a financial industry problem, not a Netflix strategy problem per se. Some growth estimates are just crazy. *cough* AI *cough*) Now, the last time Netflix’s stock price crashed—circa 2022—it gave them an opening. I’d argue Netflix insiders knew they needed to expand post-COVID-19 crisis, adding advertising, cracking down on password sharing, and dabbling in sports. But if they had done that when their stock price was high, it would give folks a reason to second guess their strategy. (Arguably, last year, when Netflix pursued the Warner Bros. merger, it gave the industry a chance to review their business.) Instead, after the 2022 fall, they had the opening to make strategic changes. We may see Netflix pivot again following this latest slide. For example, the “binge versus weekly” conversation is alive and well again. Same for expanding into theaters even more. And adding both linear channels and streaming bundles. And maybe more either social, user-generated, vertical, or creator content. But the first shift came with who is making the content calls. A Message from Our Sponsor Last winter Pulp Fiction was on Netflix. For those same 90 days, it was also free, with ads, on Pluto TV and the Roku Channel. That is not a glitch, and it is not rare. The title has run on 20 different US streaming services since 2019, across 80 separate windows, and for more than 600 of those days it sat on a paid subscription service and a free ad-supported one at the same time. Almost nobody can see this, because when a title leaves a service, the record that it was ever there tends to leave with it. Reelgood keeps that record, dated to the day rather than the month: 4MM+ movie, show and episode titles across 300+ services globally, with timestamped arrivals, departures and moves across SVOD, AVOD, TVOD and vMVPD. Licensing teams price against every prior window. Rights teams check what a licensee actually delivered, and when. Pick a title you think you know: data.reelgood.com/title-availability Film - Dan Lin Want to know why I don’t opine on individual film or TV executives, especially new hires? Dan Lin. As I always caution, it’s really, really, really tough to predict which executives will succeed in new roles and which won’t. The successful head of co-production/finance partner, Rideback, Lin was considered for the head of DC Studios job before taking the job as the head of Netflix. By all accounts at the time, this was a smart hire. (That’s my read of the news coverage anyways.) But now that Netflix has fired Dan Lin, we got a slew of news stories about how he was doing a terrible job. In sports media, Bryan Curtis, new Substack writer/podcaster from The Ringer, calls this the “now you tell us” story, when you only hear the bad news after a star athlete leaves a sports team. In this case, now they tell us that Dan Lin was bad with talent after he got kicked out the door. So was Dan Lin a flop? It’s actually tough to say. While film moves faster than TV, even two years isn’t really enough time to evaluate a person’s output. The new head hasn’t really taken control. As Emily Horgan noted, it takes much longer than two years to produce animated films, so yeah, it’s definitely too early to judge in that domain. As for live-action films, I just published an article by Brandon Katz called “Netflix’s Summer of Bummer”, but I’d point out Netflix had a bad summer two years ago too. Arguably, their best summer came from KPop Demon Hunters last year and Happy Gilmore 2, the latter of which I saw credited to Lin. Then, the stories came out that Dan Lin clashed with talent, both Ben Affleck and Greta Gerwig, classic “now they tell us” factoids to explain his firing. This may have been true, but also should have been expected given that he was given the mandate to bring budgets back in check, especially after Rebel Moon. So if he made folks upset, well, that’s what he was hired to do! But also, he was described as “well-liked” at his hiring! In that case, I’m a bit sympathetic to Lin, since he may have been undercut by senior leadership, as often happens. Basically, a CEO hires a subordinate to be their “bad cop” and keep budgets in check, but then when talent complains, the CEO ends up undercutting them. That’s how I think you end up with a Narnia movie as expensive as any of the other flops, along with a film executive the town no longer likes. As a result, I think that Netflix is now executing a classic “hire the opposite” move by hiring Peter Rice. This phrase comes from my experience following football and basketball coaching decisions, where teams generally hire the opposite of who they just had. If you have an offense-minded head coach, hire the defensive guy. Or in college football, if you have a strong recruiter, then you pivot to an “X’s and Os” type of guy. Or in pro basketball, if you have a very analytically minded coach, you hire the player-friendly guy. I see that here. After dropping Scott Stuber—arguably a talent-friendly executive with lax budget control—Netflix hired the business guy to keep costs in check. Now Netflix is pivoting back to Peter Rice and presumably a more talent-friendly regime. (Disney, by the way, has done this twice: hiring business guys to succeed talent-friendly Bob Iger. It didn’t work out last time.) When it comes to Peter Rice…we’ll see! Maybe he works out, but maybe he doesn’t. I’d actually say the biggest problem is that Netflix still hasn’t solved its “IP Problem”, in that they don’t own much IP, so they just have a lower hit rate. The new executive won’t solve that. (Though buying Lionsgate would help.) Share “Content” - Bela Bajaria I almost published yesterday’s article after this column, but ended up flipping the order, because it told the story so well. So if you want the data for why Netflix is looking at TV to fix their problems, it’s in that article, this graph in particular: I know I just wrote that it’s often hard to judge executives, but Bajaria ran TV for six years and film for three and a half more. That’s more than enough to judge hit rates, and Netflix needs more hits. That’s the story. Since 2023, Netflix hasn’t had as many hit shows as it used to, and many of its previous power house TV shows have ended their runs (Stranger Things most of all). Also, many shows from 2020 to 2022 probably pre-dated Bajaria’s tenure. (That said, one thing may have been outside of Bajaria’s control, which I explain below.) Let’s lump some content strategy thoughts about Netflix and TV into one place: We’re just getting started with this issue, but the rest is for paid subscribers of the Entertainment Strategy Guy, so if you’d like to find out… Why I partially blame Squid Game for Netflix’s latest troubles… What is “the football trap”... Why it might not be the TV shows or films’ fault at all… What change I don’t think Netflix will make... How Bela Bajaria evolved Netflix’s TV strategy in smart ways… Whose departure likely submarined Bajaria’s final few years… One sneaky explanation for Netflix’s content struggles... And a whole lot more... ...please subscribe! We can only keep doing this great work with your support.
Firefly Species Lost to Science for Over 40 Years Rediscovered In a Nature Preserve in Delaware
Entomologist and ecologist Christopher Heckscher made the discovery when he noticed the firefly’s specific flash pattern
Scientists discover a hidden flaw that challenges 40 years of superconductor science
A superconducting material studied for 40 years has turned out to be far more complex than scientists believed. Advanced 3D imaging revealed a hidden patchwork of crystal structures, with unusually wide boundaries that may weaken superconductivity. The discovery challenges decades of scientific assumptions and could explain why some superconductors outperform others.
Experian Health buys eInsights to boost insurance discovery
Experian Health, the healthcare arm of global data and technology business Experian, has acquired eInsights, a healthcare technology firm that helps providers locate patient insurance coverage that was overlooked or unavailable at the point of care. The deal broadens Experian Health’s insurance discovery capabilities beyond the early stages of the revenue cycle and gives providers […]
One of Earth’s most powerful supervolcanoes is refilling with fresh magma
Deep beneath Japan’s Kikai caldera, a massive magma reservoir is refilling 7,300 years after one of the most powerful volcanic eruptions in Earth's recent geological history. Scientists used underwater seismic surveys to reveal a vast store of magma that appears to have accumulated since the ancient catastrophe. The discovery could help explain how supervolcanoes like Yellowstone and Toba rebuild their magma supplies.
What is a neutrino anyway? A look at the science behind this year's Nobel Prize in Physics
If you wanted a Nobel Prize, you would do well to study neutrinos. To date, the Nobel Prize in Physics has been awarded five times to research related to neutrino detection and discovery. This year, Francis ...
PACK EXPO International 2026 Delivers Innovation, Connections, and Business Opportunities in Chicago
The largest, most comprehensive packaging and processing event in North America brings together the industry for four days of technology discovery, education, and business connections.
A Typography Geek Pointed Out Something About The Space Shuttle Discovery And Now I Can't Unsee It
Even though I was born in the Apollo Era, barely, the spacecraft that I think had the most influence on my childhood had to be the Space Shuttles. I remember poring over diagrams and drawings of the shuttles in National Geographic foldouts, where they even took my attention from the Forbidden Nipples seen on some of the […]
Oxford scientists discover how viruses build themselves without a blueprint
Scientists have captured virus-like particles assembling themselves step by step, revealing how a surprisingly simple process of trial and error produces complex structures with remarkable precision. The discovery uncovers a crucial molecular turning point that speeds up assembly and could lead to new ways to disrupt viruses and develop vaccines.
Video: Opinion | Inside the White House’s Push for More A.I.
The Trump administration’s plan to supercharge scientific discovery.
How AI is transforming research discovery in Web of Science
Web of Science is evolving to help researchers search, explore, and work with trusted literature in more flexible, transparent, and AI-supported ways.
Founders’ Day ceremony celebrates 65 years of discovery at Cox Science Center & Aquarium
WPEC CBS 12 provides local news, weather, sports, traffic and entertainment for West Palm Beach and nearby towns and communities in South Florida including the Palm Beaches and Treasure Coast, serving Stuart, Royal Palm Beach, Fort Pierce, Vero Beach, Port St. Lucie, Okeechobee, Jupiter, Palm Beach Gardens, Wellington, Delray Beach, Boca Raton, Lake Worth, Boynton Beach, Greenacres, Belle Glade, Palm Beach, and Riviera Beach.
James Webb telescope discovers surprising trove of metals around the Milky Way's supermassive black hole
New observations from the James Webb Space Telescope reveal a concentration of heavy metals near the Milky Way's central black hole. The discovery deepens a mystery about why our black hole behaves the way it does.
Florida State University computer scientist wins $100,000 grand prize at Discovery Days event
A Florida State University computer scientist won a $100,000 grand prize from cybersecurity company ReliaQuest after delivering a winning pitch for Sage,
Oak Ridge museum hosts free nuclear science events Saturday
The American Museum of Science and Energy offers free admission this Saturday for Nuclear Energy Discovery Day.
Oak Ridge museum hosts free nuclear science events Saturday
The American Museum of Science and Energy offers free admission this Saturday for Nuclear Energy Discovery Day.
Too much RNA can starve cells of energy, scientists discover
Scientists have uncovered an unexpected danger lurking inside cells: too much RNA can damage the structures responsible for producing energy. A new study found that excess RNA, including the normally essential messenger RNA (mRNA), can directly disrupt mitochondria without relying on the immune system. The discovery could help explain how viral infections and certain aging-related diseases damage cells.
A train was delayed by a solar storm. But something didn't add up.
Scientists have cracked a 178-year-old mystery surrounding a train delayed by a solar storm, revealing that the famous incident happened in 1848 rather than 1841. The discovery rewrites the early history of space weather and highlights a threat that still endangers modern power grids, satellites, and communication systems.
Google Cloud, DeepMind, and the EU: A New Model for AI-Driven Science
Google's latest European research initiative signals a shift toward collaborative AI innovation, where technology developers provide the tools and scientific institutions establish the priorities for discovery.